Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponatinib versus imatinib-based frontline therapy in older adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
2018-003350-25Phase 2Unknown
- Sponsor
- Cardiff University
- Start
- Jul 2019
- Modality
- Small Molecules, T-cell Engagers → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, scFv Fragments → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute lymphoblastic leukemia (ALL) comparing Ponatinib plus chemotherapy, Ponatinib plus blinatumomab and Imatinib plus chemotherapy (3 arms). Status: unknown.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2018-003350-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003350-25.